5 results
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
interrupted schedule (e.g ... interrupted schedule (e.g ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
Causes of Fatigue - Differential Diagnosis Algorithm
Endocrine
 • Hypo/Hyperthyroidism
 • Diabetes
 • Pituitary Insufficiency
 • Adrenal
• Malignancy Infectious ... Chronic Obstructive Pulmonary ... Disease Neurologic ... Myasthenia Gravis Pharmacologic ... • Drug Abuse (e.g
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
with positive serology ... (Diffuse Pulmonary ... amphotericin B 3–5 mg/kg ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
Cytomegalovirus Infections ... other factors (e.g ... control of the infection ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
count monitoring (e.g ... opportunistic #infections ... #HIVAIDS #management ... #pharmacology